[1] World report on vision[Z]. World Health Organization,2019.
[2] Weinreb R N, Aung T, Medeiros F A. The pathophysiology and treatment of glaucoma: a review[J]. JAMA,2014,311(18):1901-1911.
[3] Youngblood H, Hauser M A, Liu Y. Update on the genetics of primary open-angle glaucoma[J]. Exp Eye Res,2019,188:107795.
[4] Girkin C A, Fazio M A, Bowd C, et al. Racial Differences in the Association of Anterior Lamina Cribrosa Surface Depth and Glaucoma Severity in the African Descent and Glaucoma Evaluation Study (ADAGES)[J]. Invest Ophthalmol Vis Sci,2019,60(13):4496-4502.
[5] Garg A, Vickerstaff V, Nathwani N, et al. Primary Selective Laser Trabeculoplasty for Open-Angle Glaucoma and Ocular Hypertension: Clinical Outcomes, Predictors of Success, and Safety from the Laser in Glaucoma and Ocular Hypertension Trial[J]. Ophthalmology,2019,126(9):1238-1248.
[6] Ho C H, Wong J. Role of 24-Hour Intraocular Pressure Monitoring in Glaucoma Management[J]. J Ophthalmol,2019,2019:3632197.
[7] Asrani S, Robin A L, Serle J B, et al. Netarsudil/Latanoprost Fixed-Dose Combination for Elevated Intraocular Pressure: Three-Month Data from a Randomized Phase 3 Trial[J]. Am J Ophthalmol,2019,207:248-257.
[8] Krishnan A, Kocab A J, Zacks D N, et al. A small peptide antagonist of the Fas receptor inhibits neuroinflammation and prevents axon degeneration and retinal ganglion cell death in an inducible mouse model of glaucoma[J]. J Neuroinflammation,2019,16(1):184.
[9] Harrell C R, Fellabaum C, Arsenijevic A, et al. Therapeutic Potential of Mesenchymal Stem Cells and Their Secretome in the Treatment of Glaucoma[J]. Stem Cells Int,2019,2019:7869130.
[10] Chao L, Na L, Bin L, et al. A meta-analysis of neuroprotective effect for traditional Chinese medicine (TCM) in the treatment of glaucoma[J]. Open Med (Wars),2016,11(1):25-30.
[11] Yang M, Chen J L, Xu L W, et al. Navigating traditional chinese medicine network pharmacology and computational tools[J]. Evid Based Complement Alternat Med,2013,2013:731969.
[12] Ru J, Li P, Wang J, et al. TCMSP: a database of systems pharmacology for drug discovery from herbal medicines[J]. J Cheminform,2014,6:13.
[13] Barrett T, Troup D B, Wilhite S E, et al. NCBI GEO: mining tens of millions of expression profiles--database and tools update[J]. Nucleic Acids Res,2007,35(Database issue):D760-D765.
[14] Trott O, Olson A J. AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading[J]. J Comput Chem,2010,31(2):455-461.
[15] Shareef S R, Garcia-Valenzuela E, Salierno A, et al. Chronic ocular hypertension following episcleral venous occlusion in rats[J]. Exp Eye Res,1995,61(3):379-382.
[16] OSBORNE N N. Mitochondria: Their role in ganglion cell death and survival in primary o pen angle glaucoma[J]. Exp Ey e Res,2010,90( 6) : 750-757.
[17] Flammer J, Orgül S, Costa V P, et al. The impact of ocular blood flow in glaucoma[J]. Prog Retin Eye Res,2002,21(4):359-393.
[18] Izzotti A, Bagnis A, Saccà S C. The role of oxidative stress in glaucoma[J]. Mutat Res, 2006, 612 (2) :105-114.
[19] Vohra R, Tsai J C, Kolko M. The role of inflammation in the pathogenesis of glaucoma[J]. Surv Ophthalmol,2013,58(4):311-320.
[20] Zhou X, Li G, Zhang S, et al. 5-HT1A Receptor Agonist Promotes Retinal Ganglion Cell Function by Inhibiting OFF-Type Presynaptic Glutamatergic Activity in a Chronic Glaucoma Model[J]. Front Cell Neurosci,2019,13:167
[21]Qu J, Wang D, Grosskreutz C L. Mechanisms of retinal ganglion cell injury and defense in glaucoma[J]. Experimental Eye Research, 2010,91(1):48-53.DOI:10.1016/j.exer.2010.04.002.
[22] Anderson DR. Normal-tension glaucoma( Low-tension glaucoma) [J]. Indian J Ophthalmol,2011,59 Suppl: S97-101.
[23] LI WJ, PENG QH, TAN HY. Neuroprotective effects of traditional Chinese medicine in treating glaucoma: A Met-analysis [J]. Int Eye Sci, 2013,13(04):671-673.
[24] SUI JQ,HUO J,LIU LS, et al. Research progress of traditional Chinese medicine in treatment of primary open angle glaucoma[J]. CJTCMP, 2020,35(01):325-327.
[25]Li S, Fan T P, Jia W, et al. Network pharmacology in traditional Chinese medicine[J]. 2014.
[26] LV BC, XU ZG, CHEN T, et al. A comparative study on protective effect of optical nerve between crocin and erigeron breviscapus in chronic ocular hypertensive rats [J]. Chinese Journal Of Experimental Ophthalmology, 2016,34(11):990-996.
[27] ZHAO Y, XU YJ, DUAN JG, et al. Effects of lycium bararum polysaccharides on delayed rectifier K+ current in high pressure-induced apoptosis of retinal ganglion cells [J]. Rec Adv Ophthalmol, 2016,36(06):520-523.
[28] LU XJ, ZHANG FW, ZHANG Y, et al. Protective Effect of Flavonoids of Herba Erigeronis Breviscapi on Visual Function [J]. Traditional Chinese Drug Research & Clinical Pharmacology, 2011,22(05):510-514.
[29] SHI S, YUAN Y. Traditional Chinese medicine treatment of glaucoma [J]. Chinese Journal of Practical Ophthalmology, 2007(06):559-562.
[30] LI YJ, YANG XG, GAO ZR. Effects of Extracts of Ginkgo Biloba (EGB) on Levels of Nitric Oxide and Apoptosis in the Retina Induced by Glutamate in Adult Rabbits [J]. China Journal of Chinese Materia Medica, 2003(10):67-70.
[31] Li H B, You Q S, Xu L X, et al. Long Non-Coding RNA-MALAT1 Mediates Retinal Ganglion Cell Apoptosis Through the PI3K/Akt Signaling Pathway in Rats with Glaucoma[J]. Cell Physiol Biochem,2017,43(5):2117-2132.
[32] Inoue-Mochita M, Inoue T, Kojima S, et al. Interleukin-6-mediated trans-signaling inhibits transforming growth factor-β signaling in trabecular meshwork cells[J]. J Biol Chem,2018,293(28):10975-10984.
[33] Hernandez M R, Miao H, Lukas T. Astrocytes in glaucomatous optic neuropathy[J]. Prog Brain Res,2008,173:353-373.
[34] Sun D, Moore S, Jakobs T C. Optic nerve astrocyte reactivity protects function in experimental glaucoma and other nerve injuries[J]. J Exp Med,2017,214(5):1411-1430.
[35] Gui D, Li Y, Chen X, et al. HIF‑1 signaling pathway involving iNOS, COX‑2 and caspase‑9 mediates the neuroprotection provided by erythropoietin in the retina of chronic ocular hypertension rats[J]. MOL MED REP, 2015, 11(2): 1490-1496.
[36] Miyamoto N, Izumi H, Miyamoto R, et al. Nipradilol and timolol induce Foxo3a and peroxiredoxin 2 expression and protect trabecular meshwork cells from oxidative stress[J]. INVEST OPHTH VIS SCI, 2009, 50(6): 2777-2784.
[37] Yang X, Zeng Q, Barış M, et al. Transgenic inhibition of astroglial NF-κB restrains the neuroinflammatory and neurodegenerative outcomes of experimental mouse glaucoma[J]. J NEUROINFLAMM, 2020, 17(1): 1-18.
[38] Lozano D C, Choe T E, Cepurna W O, et al. Early optic nerve head glial proliferation and Jak-Stat pathway activation in chronic experimental glaucoma[J]. INVEST OPHTH VIS SCI, 2019, 60(4): 921-932.
[39] Niittykoski M, Kalesnykas G, Larsson K P, et al. Altered calcium signaling in an experimental model of glaucoma[J]. INVEST OPHTH VIS SCI, 2010, 51(12): 6387-6393.
[40] ZHANG YY, LI ZD, JIANG N, et al. Effect and mechanism of baicalin on optic nerve injury in mice with acute intraocular hypertension [J]. Chinese Journal of Ophthalmology, 2020(05):376-382.
[41]Ye D, Shi Y, Xu Y, et al. PACAP attenuates optic nerve crush-induced retinal ganglion cell apoptosis via activation of the CREB-Bcl-2 pathway[J]. Journal of Molecular Neuroscience, 2019, 68(3): 475-484.
[42] Maes M E, Schlamp C L, Nickells R W. BAX to basics: How the BCL2 gene family controls the death of retinal ganglion cells[J]. Progress in retinal and eye research, 2017, 57: 1-25.